Related Experiment Video
Updated: Jan 9, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
[Erectile dysfunction : an angiological perspective]
Konstantinos-Cédric Perdikis1, Marc Righini1
1Service d'angiologie et d'hémostase, Département de médecine, Hôpitaux universitaires de Genève, 1211 Genève 14.
Abstract:
Erectile dysfunction is a common condition that is most often reported after the age of 40, though it can occur at any age. A vascular origin is the most frequent organic cause. Diagnosis relies on an integrated sexual medicine approach, which uses tools such as penile pharmaco-doppler sonography to allow for a more precise etiological assessment. Regardless of the underlying etiology, management of cardiovascular risk factors remains essential. While phosphodiesterase type 5 inhibitors are the first-line therapy, new therapeutic options and vascular interventions are emerging, offering more personalized management perspectives.
Related Concept Videos
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Angina III: Clinical Manifestations and Assessment
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Angina I: Introduction
Angina IV: Management
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...

